Metadata Search
ALS Therapy Development Institute
Page 1 of 1 results
Sort by: relevance publication year Download as CSV

Phase IIa trial of fingolimod for amyotrophic lateral sclerosis demonstrates acceptable acute safety and tolerability

Journal Article published 29 Aug 2017 in Muscle & Nerve volume 56 issue 6 on pages 1077 to 1084

Research funded by ALS Therapy Development Institute | Novartis

Authors: James D. Berry, Sabrina Paganoni, Nazem Atassi, Eric A. Macklin, Namita Goyal, Michael Rivner, Ericka Simpson, Stanley Appel, Daniela L. Grasso, Nicte I. Mejia, Farrah Mateen, Alan Gill, Fernando Vieira, Valerie Tassinari, Steven Perrin